Hugh M. Cole, Chief Business Officer at Jounce Therapeutics, Inc. (JNCE), sold 2,336 shares at $4.00 ($9K) on 2019-08-15, disclosed to the SEC on 2019-08-16.
Open-market sale of $9k JNCE by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.10 | 670 | $3K | 29.4% |
| 2 | $4.00 | 648 | $3K | 27.8% |
| 3 | $3.92 | 1,018 | $4K | 42.8% |
| Total | $3.99 avg | 2,336 | $9K | 100% |
| Filing → |
| JNCE | SELL | 2021-01-25 | $215K | — | Filing → |
| JNCE | SELL | 2021-01-11 | $43K | — | Filing → |
| JNCE | SELL | 2020-08-18 | $10K | — | Filing → |